Boardroom Alpha
Boardroom Alpha
CBT · Current Report (Form 8-K) · Filed August 21, 2026

Cabot Corp — Current Report (Form 8-K)

Form
8-K
Filed
August 21, 2026
Period
Aug 21, 2026
Ticker
CBT
Accession
0001193125-26-361109
Boardroom Alpha · Filing insights

Cabot issued $350 million of 4.950% senior notes due 2029. Proceeds will redeem $250 million of 3.40% notes due 2026 and fund working capital and general corporate purposes.

About Cabot Corp
Market cap
$4.3B
1Y TSR
+11.6%
3Y TSR
+9.1%
Board grade
C+
Sector
Basic Materials
CEO
Erica McLaughlin
Last annual meeting: Mar 12, 2026 · View full Cabot Corp profile →
8-K
 
 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

 

FORM 8-K

 

 

CURRENT REPORT PURSUANT

TO SECTION 13 OR 15(D)

OF THE SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported): August 21, 2026

 

 

CABOT CORPORATION

(Exact Name of Registrant as Specified in Its Charter)

 

 

 

Delaware   001-05667   04-2271897

(State or Other Jurisdiction

of Incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

 

2 Seaport Lane, Suite 1400, Boston,

Massachusetts

  02210-2019
(Address of Principal Executive Offices)   (Zip Code)

Registrant’s Telephone Number, Including Area Code: (617) 345-0100

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Securities Exchange Act of 1934:

 

Title of each class

 

Trading
Symbol(s)

 

Name of each exchange
on which registered

Common Stock, $1 par value per share   CBT   New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 
 


Item 8.01 Other Events.

On August 21, 2026, Cabot Corporation (“Cabot”) completed the issuance and sale of $350 million aggregate principal amount of 4.950% senior notes due 2029 (the “Notes”).

The offering of the Notes was registered pursuant to an automatically effective shelf registration statement on Form S-3ASR under the Securities Act of 1933, as amended (Registration Statement No. 333-276078) (the “Registration Statement”), that was filed with the Securities and Exchange Commission on December 15, 2023.

The Notes were issued pursuant to an indenture (the “Base Indenture”), between Cabot and U.S. Bank Trust Company, National Association, as trustee (the “Trustee”) dated as of June 22, 2022, as supplemented by the Second Supplemental Indenture (the “Second Supplemental Indenture”), dated as of August 21, 2026, between Cabot and the Trustee. Cabot is filing the Second Supplemental Indenture as Exhibit 4.2, to this Current Report on Form 8-K. In order to furnish as an exhibit for incorporation by reference into the Registration Statement, Cabot is filing the opinion of Ropes & Gray LLP relating to the validity of the Notes as Exhibit 5.1 to this Current Report on Form 8-K

Cabot intends to use the net proceeds of the offering to redeem its $250 million aggregate principal amount of 3.40% Senior Notes due September 2026, with the remainder being used for working capital and other general corporate purposes (including, at Cabot’s discretion, repayment of commercial paper and amounts, if any, outstanding under its multicurrency revolving credit facility).

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

 

Exhibit 4.1    Indenture, dated June 22, 2022, between Cabot Corporation and U.S. Bank Trust Company, National Association (incorporated by reference to Exhibit 4.1 to the Current Report on Form 8-K filed on June 22, 2022).
Exhibit 4.2    Second Supplemental Indenture, dated August 21, 2026, between Cabot Corporation and U.S. Bank Trust Company, National Association, including the form of Global Note attached as Annex A thereto.
Exhibit 5.1    Opinion of Ropes & Gray LLP as to the validity of the Notes.
Exhibit 23.1    Consent of Ropes & Gray LLP (included in Exhibit 5.1).
Exhibit 104    Cover Page Interactive Data File (embedded within the Inline XBRL document).

 


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

CABOT CORPORATION
By:  

/s/ Erica McLaughlin

  Erica McLaughlin
  Executive Vice President and Chief Financial Officer

Date: August 21, 2026

From this filing to the file

Every SEC filing, parsed structured.

Boardroom Alpha indexes every 8-K, 10-K, 10-Q, and proxy back to 2000 — vote tabulations, comp tables, red flags, insider transactions, all queryable the day they hit EDGAR.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Cabot Corp (CBT)

Reference

Frequently asked questions

When did Cabot Corp file this 8-K?
Cabot Corp (CBT) filed this Current Report (Form 8-K) with the SEC on August 21, 2026. The accession number assigned by EDGAR is 0001193125-26-361109.
What does an 8-K disclose?
Form 8-K is the SEC's current-report form, used to disclose material events between periodic reports (10-K / 10-Q). Triggers include CEO/CFO departures, acquisitions, bankruptcies, earnings releases, auditor changes, changes in fiscal year, and amendments to corporate governance. Each 8-K is keyed to one or more Item numbers (1.01 through 9.01).
What is the key takeaway from this filing?
Cabot issued $350 million of 4.950% senior notes due 2029. Proceeds will redeem $250 million of 3.40% notes due 2026 and fund working capital and general corporate purposes. This is Boardroom Alpha's one-line summary of the current report; see the full filing text above for the formal disclosure.
What Item codes does an 8-K cover?
An 8-K's Item codes (1.01 through 9.01) specify what kind of event is being disclosed — e.g. Item 1.01 for entering a material agreement, Item 5.02 for departure/election of directors and executive officers, Item 8.01 for other events. The Item codes for this 8-K appear in the filing text above.
Where can I find Cabot Corp's prior current reports on EDGAR?
The SEC EDGAR browser lists every 8-K Cabot Corp has filed under CIK 16040, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer